Print version Decrease text Increase text

HIV/AIDS, Malaria and Tuberculosis

The European Commission's Research Framework Programme 7, FP7 (2007-2013) is funding research aimed at combating the three major killer diseases, HIV/AIDS, Malaria and Tuberculosis (Poverty related diseases, PRDs).

Research on HIV/AIDS, Malaria and Tuberculosis focuses on developing new therapies and diagnostic and preventive tools, such as vaccines and HIV Microbicides. The programme is sponsoring research on the full spectrum, from basic molecular research through to preclinical tests and proof-of-principle studies. Research efforts confront the three diseases at global level, but also address specific European aspects. Structures that were successfully built under FP6 (2002-2006) are reinforced and complemented in FP7.

Detailed descriptions of the specific themes, calls and proposal submission dates are specified in the different calls for proposals and can be found on the main website.

Highlights

Graphic elementPACTR launches online interactive map of clinical trials in Africa
Read more...
Graphic element Fighting Malaria: EU Research and Innovation role
Read more...
Graphic elementEU research fighting the three major deadly diseases: HIV/AIDS, Malaria and Tuberculosis
Read more...

Graphic elementThe European Union to confront HIV/AIDS Prevention, treatment, research and support
Read more...

Graphic elementEuropean research on HIV/AIDS
Read more...
Graphic element ECDC: European Centre for Disease Prevention and Control
Read more...
Graphic element CANTAM, first EDCTP-funded African Network of Excellence
Read more...






Valid XHTML 1.0 Transitional